These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9226681)

  • 21. Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans.
    Zhang W; Zhang Z; Shi B; Li J; You H; Tulson G; Dang X; Song Y; Yimiti T; Wang J; Jones MK; McManus DP
    J Infect Dis; 2006 Oct; 194(7):966-74. PubMed ID: 16960785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of orf virus as a bifunctional recombinant vaccine: surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins.
    Tan JL; Ueda N; Heath D; Mercer AA; Fleming SB
    Vaccine; 2012 Jan; 30(2):398-406. PubMed ID: 22085551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.
    Petavy AF; Hormaeche C; Lahmar S; Ouhelli H; Chabalgoity A; Marchal T; Azzouz S; Schreiber F; Alvite G; Sarciron ME; Maskell D; Esteves A; Bosquet G
    PLoS Negl Trop Dis; 2008 Jan; 2(1):e125. PubMed ID: 18235847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning of an echinococcal microtrichal antigen immunoreactive in Echinococcus multilocularis disease.
    Frosch PM; Geier C; Kaup FJ; Müller A; Frosch M
    Mol Biochem Parasitol; 1993 Apr; 58(2):301-10. PubMed ID: 8479454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological responses and potency of the EG95NC
    Jazouli M; Lightowlers MW; Bamouh Z; Gauci CG; Tadlaoui K; Ennaji MM; Elharrak M
    Parasitol Int; 2020 Oct; 78():102149. PubMed ID: 32464256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cloning and sequence analysis of Eg95 cDNA from different stages of Echinococcus granulosus in Xinjiang].
    Lin RY; Ding JB; Wen H; Zhang WB; Li J; Lu XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):170-2. PubMed ID: 14628351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work.
    Larrieu E; Mujica G; Araya D; Labanchi JL; Arezo M; Herrero E; Santillán G; Vizcaychipi K; Uchiumi L; Salvitti JC; Grizmado C; Calabro A; Talmon G; Sepulveda L; Galvan JM; Cabrera M; Seleiman M; Crowley P; Cespedes G; García Cachau M; Gino L; Molina L; Daffner J; Gauci CG; Donadeu M; Lightowlers MW
    Acta Trop; 2019 Mar; 191():1-7. PubMed ID: 30576624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site.
    Marsland BJ; Tisdall DJ; Heath DD; Mercer AA
    Arch Virol; 2003 Mar; 148(3):555-62. PubMed ID: 12607106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).
    Heath DD; Robinson C; Shakes T; Huang Y; Gulnur T; Shi B; Zhang Z; Anderson GA; Lightowlers MW
    Vaccine; 2012 Apr; 30(20):3076-81. PubMed ID: 22406459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps.
    Gauci C; Vural G; Oncel T; Varcasia A; Damian V; Kyngdon CT; Craig PS; Anderson GA; Lightowlers MW
    Int J Parasitol; 2008 Jul; 38(8-9):1041-50. PubMed ID: 18160069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
    Alvarez Rojas CA; Gauci CG; Lightowlers MW
    Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncospheral penetration glands are the source of the EG95 vaccine antigen against cystic hydatid disease.
    Jabbar A; Jenkins DJ; Crawford S; Walduck AK; Gauci CG; Lightowlers MW
    Parasitology; 2011 Jan; 138(1):89-99. PubMed ID: 20663253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines against cysticercosis and hydatidosis.
    Lightowlers MW; Gauci CG
    Vet Parasitol; 2001 Nov; 101(3-4):337-52. PubMed ID: 11707305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination Against Hydatidosis: Molecular Cloning and Optimal Expression of the EG95NC
    Jazouli M; Lightowlers M; Gauci CG; Tadlaoui K; Belmlih A; Ennaji MM; Elharrak M
    Protein J; 2017 Dec; 36(6):472-477. PubMed ID: 29139018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of recombinant goatpox virus expressing Echinococcus granulosus EG95 vaccine antigen.
    Liu F; Fan X; Li L; Ren W; Han X; Wu X; Wang Z
    J Virol Methods; 2018 Nov; 261():28-33. PubMed ID: 30086380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
    Heath DD; Koolaard J
    Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of cystic echinococcosis in the Middle Atlas, Morocco: Field evaluation of the EG95 vaccine in sheep and cesticide treatment in dogs.
    Amarir F; Rhalem A; Sadak A; Raes M; Oukessou M; Saadi A; Bouslikhane M; Gauci CG; Lightowlers MW; Kirschvink N; Marcotty T
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009253. PubMed ID: 33684115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum.
    Tsuji N; Suzuki K; Kasuga-Aoki H; Isobe T; Arakawa T; Matsumoto Y
    Infect Immun; 2003 Sep; 71(9):5314-23. PubMed ID: 12933879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of cytokine secretion in mice by immunization with leaf protein extracted from Echinococcus granulosus Eg95-EgA31 transgenic alfalfa].
    Ye YJ; Li WG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Apr; 28(2):94-7. PubMed ID: 20666308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel in silico minigene vaccine based on CD4
    Pourseif MM; Moghaddam G; Naghili B; Saeedi N; Parvizpour S; Nematollahi A; Omidi Y
    Comput Biol Chem; 2018 Feb; 72():150-163. PubMed ID: 29195784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.